Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John G Matthews

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Advances in Pharmacology (San Diego, Calif.)|February 26, 2013
Redefining approaches to asthma: developing targeted biologic therapiesJoseph R Arron, Heleen Scheerens, John G Matthews
Annals of the American Thoracic Society|December 10, 2013
Noninvasive biomarkers that predict treatment benefit from biologic therapies in asthmaJoseph R Arron, David F Choy, Heleen Scheerens, et al.
The Journal of Allergy and Clinical Immunology|June 23, 2004
Defective glucocorticoid receptor nuclear translocation and altered histone acetylation patterns in glucocorticoid-resistant patientsJohn G Matthews, Kazuhiro Ito, Peter J Barnes, et al.
The Journal of Allergy and Clinical Immunology|April 10, 2002
p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthmaElvis Irusen, John G Matthews, Atsushi Takahashi, et al.
The Journal of Allergy and Clinical Immunology|November 8, 2006
Expression of nonmuscle cofilin-1 and steroid responsiveness in severe asthmaNisha Vasavda, Thomas Eichholtz, Atsushi Takahashi, et al.
American Journal of Respiratory and Critical Care Medicine|January 13, 2016
Roles of Periostin in Respiratory DisordersKenji Izuhara, Simon J Conway, Bethany B Moore, et al.
The AAPS Journal|February 16, 2013
Population-based efficacy modeling of omalizumab in patients with severe allergic asthma inadequately controlled with standard therapyRui Zhu, Yanan Zheng, Wendy S Putnam, et al.
BMJ Open Respiratory Research|December 6, 2019
Seasonal variability of lung function and Asthma Quality of Life Questionnaire Scores in adults with uncontrolled asthmaRebecca N Bauer, Xiaoying Yang, Tracy L Staton, et al.
Thorax|July 20, 2018
Change in biomarkers of type-2 inflammation following severe exacerbations of asthmaRuth Semprini, Nick Shortt, Stefan Ebmeier, et al.
The Journal of Allergy and Clinical Immunology|June 4, 2013
Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroidsMichael Noonan, Phillip Korenblat, Sofia Mosesova, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Advances in Pharmacology (San Diego, Calif.)|February 26, 2013
Redefining approaches to asthma: developing targeted biologic therapiesJoseph R Arron, Heleen Scheerens, John G Matthews
Annals of the American Thoracic Society|December 10, 2013
Noninvasive biomarkers that predict treatment benefit from biologic therapies in asthmaJoseph R Arron, David F Choy, Heleen Scheerens, et al.
The Journal of Allergy and Clinical Immunology|June 23, 2004
Defective glucocorticoid receptor nuclear translocation and altered histone acetylation patterns in glucocorticoid-resistant patientsJohn G Matthews, Kazuhiro Ito, Peter J Barnes, et al.
The Journal of Allergy and Clinical Immunology|April 10, 2002
p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthmaElvis Irusen, John G Matthews, Atsushi Takahashi, et al.
The Journal of Allergy and Clinical Immunology|November 8, 2006
Expression of nonmuscle cofilin-1 and steroid responsiveness in severe asthmaNisha Vasavda, Thomas Eichholtz, Atsushi Takahashi, et al.
American Journal of Respiratory and Critical Care Medicine|January 13, 2016
Roles of Periostin in Respiratory DisordersKenji Izuhara, Simon J Conway, Bethany B Moore, et al.
The AAPS Journal|February 16, 2013
Population-based efficacy modeling of omalizumab in patients with severe allergic asthma inadequately controlled with standard therapyRui Zhu, Yanan Zheng, Wendy S Putnam, et al.
BMJ Open Respiratory Research|December 6, 2019
Seasonal variability of lung function and Asthma Quality of Life Questionnaire Scores in adults with uncontrolled asthmaRebecca N Bauer, Xiaoying Yang, Tracy L Staton, et al.
Thorax|July 20, 2018
Change in biomarkers of type-2 inflammation following severe exacerbations of asthmaRuth Semprini, Nick Shortt, Stefan Ebmeier, et al.
The Journal of Allergy and Clinical Immunology|June 4, 2013
Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroidsMichael Noonan, Phillip Korenblat, Sofia Mosesova, et al.
Pageof 3